Abstract
The most common surrogates of kidney function are serum creatinine, urea, cystatin C; however, these all have limitations, most important of which is that they do not accurately reflecting real-time dynamic changes in glomerular filtration rate (GFR) that occur in acute kidney injury (AKI) The Cockcroft-Gault and Modification of Diet in Renal Disease (MDRD) Study Group equations are the most common methods used to estimate GFR; however, they have limited relevance to critically ill patients with AKI. Urine output can be a sensitive indicator for changes in renal hemodynamics, but it also has limited sensitivity and specificity Several tests of urinary biochemistry, derived indices and microscopy (i.e., FENa, UNa, FEU) have traditionally been used as aids for the detection and classification of AKI; however, their value in sick patients (i.e., after fluid resuscitation, diuretics, vasopressor infusions, radiocontrast media, and nephrotoxic drugs) remains uncertain Novel urinary biomarkers (i.e., NHE3, NGAL, KIM-1, IL-18) have recently been characterized that may provide added diagnostic value and prognostic information for critically ill patients in AKI.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bagshaw SM, Laupland KB, Doig CJ, et al. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care. 2005;9:R700–R709
de Mendonca A, Vincent JL, Suter PM, et al. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med. 2000;26:915–921
Liano F, Junco E, Pascual J, Madero R, Verde E. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int Suppl. 1998;66: S16–24
Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813–818
Metnitz PG, Krenn CG, Steltzer H, et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med. 2002;30:2051–2058
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8: R204–212
Uchino S, Bellomo R, Goldsmith D, Bates S, Kellum J, Ronco C. An Assessment of the RIFLE Criteria for Acute Renal Failure in Hospitalized Patients. Crit Care Med. 2006;34:1913–1917
Hoste EA, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006;10:R73
Hoste EAJ, Kellum JA. Acute kidney injury: epidemiology and diagnostic criteria. Curr Opin Crit Care. 2006;12: 531–537
Stevens LA, Levey AS. Measurement of kidney function. Med Clin North Am. 2005;89:457–473
Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985;28:830–838
Grossman RA, Hamilton RW, Morse BM, Penn AS, Goldberg M. Nontraumatic rhabdomyolysis and acute renal failure. N Engl J Med. 1974;291:807–811
Oh MS. Does serum creatinine rise faster in rhabdomyolysis? Nephron. 1993;63:255–2557
Molitch ME, Rodman E, Hirsch CA, Dubinsky E. Spurious serum creatinine elevations in ketoacidosis. Ann Intern Med. 1980;93:280–281
Kaji DM, Lim J, Shilkoff W, Zaidi W. Urea inhibits the Na-K pump in human erythrocytes. J Membr Biol. 1998;165: 125–131
Lim J, Gasson C, Kaji DM. Urea inhibits NaK2Cl cotransport in human erythrocytes. J Clin Invest. 1995;96: 2126–2132
Prabhakar SS, Zeballos GA, Montoya-Zavala M, Leonard C. Urea inhibits inducible nitric oxide synthase in macrophage cell line. Am J Physiol. 1997;273:C1882–1888
Chalasani N, Clark WS, Wilcox CM. Blood urea nitrogen to creatinine concentration in gastrointestinal bleeding: a reappraisal. Am J Gastroenterol. 1997;92:1796–1799
Sherman DS, Fish DN, Teitelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis. 2003;41:269–278
Papadakis MA, Arieff AI. Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study. Am J Med. 1987;82:945–952
Han WK, Bonventre JV. Biologic markers for the early detection of acute kidney injury. Curr Opin Crit Care. 2004; 10:476–482
Herget-Rosenthal S, Feldkamp T, Volbracht L, Kribben A. Measurement of urinary cystatin C by particle-enhanced nephelometric immunoassay: precision, interferences, stability and reference range. Ann Clin Biochem. 2004;41: 111–118
Herget-Rosenthal S, Kribbin A. Urinary cystatin C: pre-analytical and analytical characteristics and its clinical application. Dade Behring J. 2004:13–15
Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004; 65:1416–1421
Manetti L, Genovesi M, Pardini E, et al. Early effects of methylprednisolone infusion on serum cystatin C in patients with severe Graves’ ophthalmopathy. Clin Chim Acta. 2005; 356:227–228
Manetti L, Pardini E, Genovesi M, et al. Thyroid function differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest. 2005;28:346–349
Rule AD, Larson TS. Response to ‘Calculation of glomerular filtration rate using serum cystatin C in kidney transplant recipients’. Kidney Int. 2006;70:1878–1879
Villa P, Jimenez M, Soriano MC, Manzanares J, Casasnovas P. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. Crit Care. 2005;9: R139–143
Coll E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36:29–34
Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant. 2003;18:2024–2031
Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40:221–226
Grubb A, Bjork J, Lindstrom V, Sterner G, Bondesson P, Nyman U. A cystatin C-based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft-Gault formula. Scand J Clin Lab Invest. 2005;65: 153–162
Grubb A, Nyman U, Bjork J, et al. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem. 2005;51:1420–1431
Poge U, Gerhardt T, Stoffel-Wagner B, et al. Cystatin C-based calculation of glomerular filtration rate in kidney transplant recipients. Kidney Int. 2006;70:204–210
Poge U, Gerhardt T, Stoffel-Wagner B, Klehr HU, Sauerbruch T, Woitas RP. Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients. Nephrol Dial Transplant. 2006;21:660–664
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470
Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital-acquired renal insufficiency: a prospective study. Am J Med. 1983;74:243–248
Espinel CH. The FENa test. Use in the differential diagnosis of acute renal failure. JAMA. 1976;236:579–581
Miller TR, Anderson RJ, Linas SL, et al. Urinary diagnostic indices in acute renal failure: a prospective study. Ann Intern Med. 1978;89:47–50
Espinel CH, Gregory AW. Differential diagnosis of acute renal failure. Clin Nephrol. 1980;13:73–77
Zarich S, Fang LS, Diamond JR. Fractional excretion of sodium. Exceptions to its diagnostic value. Arch Intern Med. 1985;145:108–112
Pru C, Kjellstrand CM. The FENa test is of no prognostic value in acute renal failure. Nephron. 1984;36:20–23
Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int. 2002;62:2223–2229
Kaplan AA, Kohn OF. Fractional excretion of urea as a guide to renal dysfunction. Am J Nephrol. 1992;12:49–54
Langenberg C, Wan L, Bagshaw SM, Egi M, May CN, Bellomo R. Urinary biochemistry in experimental septic acute renal failure. Nephrol Dial Transplant. 2006
Fang L, Sirota R, Ebert T, Lichtenstein N. Low fractional excretion of sodium with contrast media-induced acute renal failure. Arch Intern Med. 1980;140:531–533
Corwin HL, Schreiber MJ, Fang LS. Low fractional excretion of sodium. Occurrence with hemoglobinuric- and myoglobinuric-induced acute renal failure. Arch Intern Med. 1984;144:981–982
Vaz AJ. Low fractional excretion of urine sodium in acute renal failure due to sepsis. Arch Intern Med. 1983;143: 738–739
Esson ML, Schrier RW. Diagnosis and treatment of acute tubular necrosis. Ann Intern Med. 2002;137:744–752
Needham E. Management of acute renal failure. Am Fam Physician. 2005;72:1739–1746
Van Biesen W, Yegenaga I, Vanholder R, et al. Relationship between fluid status and its management on acute renal failure (ARF) in intensive care unit (ICU) patients with sepsis: a prospective analysis. J Nephrol. 2005;18:54–60
Zager RA, Rubin NT, Ebert T, Maslov N. Rapid radioimmunoassay for diagnosing acute tubular necrosis. Nephron. 1980;26:7–12
Diamond JR, Yoburn DC. Nonoliguric acute renal failure associated with a low fractional excretion of sodium. Ann Intern Med. 1982;96:597–600
Cabrera J, Arroyo V, Ballesta AM, et al. Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage. Gastroenterology. 1982;82:97–105
Langenberg C, Wan L, Egi M, May CN, Bellomo R. Renal blood flow in experimental septic acute renal failure. Kidney Int. 2006;69:1996–2002
Fushimi K, Shichiri M, Marumo F. Decreased fractional excretion of urate as an indicator of prerenal azotemia. Am J Nephrol. 1990;10:489–494
Smith-Erichsen N. Renal and liver function tests in surgical septicemia. Acta Anaesthesiol Scand. 1987;31:208–213
Perlmutter M, Grossman SL, Rothenberg S, Dobkin G. Urine serum urea nitrogen ratio; simple test of renal function in acute azotemia and oliguria. JAMA 1959;170: 1533–1537
Tungsanga K, Boonwichit D, Lekhakula A, Sitprija V. Urine uric acid and urine creatine ratio in acute renal failure. Arch Intern Med. 1984;144:934–937
Chesney PJ, Davis JP, Purdy WK, Wand PJ, Chesney RW. Clinical manifestations of toxic shock syndrome. JAMA. 1981;246:741–748
Bagshaw SM, Langenberg C, Bellomo R. 2006 Urinary biochemistry and microscopy in septic acute renal failure – a systematic review. Am J Kidney Dis. 48:695–705
Thorevska N, Sabahi R, Upadya A, Manthous C, Amoateng-Adjepong Y. Microalbuminuria in critically ill medical patients: prevalence, predictors, and prognostic significance. Crit Care Med. 2003;31:1075–1081
Gay C, Cochat P, Pellet H, Floret D, Buenerd A. Urinary sediment in acute renal failure. Pediatrie. 1987;42:723–727
Graber M, Lane B, Lamia R, Pastoriza-Munoz E. Bubble cells: renal tubular cells in the urinary sediment with characteristics of viability. J Am Soc Nephrol. 1991;1:999–1004
Richmond JM, Sibbald WJ, Linton AM, Linton AL. Patterns of urinary protein excretion in patients with sepsis. Nephron. 1982;31:219–223
Strauch M, McLaughlin JS, Mansberger A, et al. Effects of septic shock on renal function in humans. Ann Surg. 1967;165:536–543
Gosling P, Brudney S, McGrath L, Riseboro S, Manji M. Mortality prediction at admission to intensive care: a comparison of microalbuminuria with acute physiology scores after 24 hours. Crit Care Med. 2003;31:98–103
Gosling P, Czyz J, Nightingale P, Manji M. Microalbuminuria in the intensive care unit: Clinical correlates and association with outcomes in 431 patients. Crit Care Med. 2006;34: 2158–2166
Gopal S, Carr B, Nelson P. Does microalbuminuria predict illness severity in critically ill patients on the intensive care unit? A systematic review. Crit Care Med. 2006;34: 1805–1810
Morcos SK, el-Nahas AM, Brown P, Haylor J. Effect of iodinated water soluble contrast media on urinary protein assays. BMJ. 1992;305:29
Lugo N, Silver P, Nimkoff L, Caronia C, Sagy M. Diagnosis and management algorithm of acute onset of central diabetes insipidus in critically ill children. J Pediatr Endocrinol Metab. 1997;10:633–639
Zaloga GP, Chernow B, McFadden E, Soldano S, Lyons P, O’Brian JT. Urine glucose testing in the critically ill: a comparison of two enzymatic test strips. Crit Care Med. 1984; 12:188–190
Brosius FC, Lau K. Low fractional excretion of sodium in acute renal failure: role of timing of the test and ischemia. Am J Nephrol. 1986;6:450–457
Marotto MS, Marotto PC, Sztajnbok J, Seguro AC. Outcome of acute renal failure in meningococcemia. Ren Fail. 1997; 19:807–810
Wan L, Bellomo R, Di Giantomasso D, Ronco C. The pathogenesis of septic acute renal failure. Curr Opin Crit Care. 2003;9:496–502
Klahr S, Miller SB. Acute oliguria. N Engl J Med. 1998; 338:671–675
Wedeen RP, Udasin I, Fiedler N, et al. Urinary biomarkers as indicators of renal disease. Ren Fail. 1999;21:241–249
Price RG, Wedeen R, Lichtveld MY, et al. Urinary biomarkers: roles in risk assessment to environmental and occupational nephrotoxins: monitoring of effects and evaluation of mechanisms of toxicity. Ren Fail. 1999;21:xiii–xviii
du Cheyron D, Daubin C, Poggioli J, et al. Urinary measurement of Na+/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF. Am J Kidney Dis. 2003;42:497–506
Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003;14:2534–2543
Mishra J, Mori K, Ma Q, Kelly C, Barasch J, Devarajan P. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol. 2004;24:307–315
Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231–1238
Wagener G, Jan M, Kim M, et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology. 2006;105:485–491
Mishra J, Ma Q, Kelly C, et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol. 2006;21:856–863
Parikh CR, Jani A, Mishra J, et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant. 2006;6: 1639–1645
Ichimura T, Bonventre JV, Bailly V, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem. 1998;273: 4135–4142
Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol. 2004;286:F552–563
Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol. 2006;290:F517–529
Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002; 62:237–244
D’Amico G, Bazzi C. Urinary protein and enzyme excretion as markers of tubular damage. Curr Opin Nephrol Hypertens. 2003;12:639–643
Kwon O, Molitoris BA, Pescovitz M, Kelly KJ. Urinary actin, interleukin-6, and interleukin-8 may predict sustained ARF after ischemic injury in renal allografts. Am J Kidney Dis. 2003;41:1074–1087
Mariano F, Guida G, Donati D, et al. Production of platelet-activating factor in patients with sepsis-associated acute renal failure. Nephrol Dial Transplant. 1999;14:1150–1157
Parikh CR, Jani A, Melnikov VY, Faubel S, Edelstein CL. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis. 2004;43:405–414
Parikh CR, Mishra J, Thiessen-Philbrook H, et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2006;70:199–203
Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol. 2005;16:3046–3052
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bagshaw, S.M. (2010). Kidney Function Tests and Urinalysis. In: Jörres, A., Ronco, C., Kellum, J. (eds) Management of Acute Kidney Problems. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69441-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-540-69441-0_10
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-69413-7
Online ISBN: 978-3-540-69441-0
eBook Packages: MedicineMedicine (R0)